Main Data
Editor: Deborah Tomlinson, Nancy E. Kline
Title: Pediatric Oncology Nursing Advanced Clinical Handbook
Publisher: Springer-Verlag
ISBN/ISSN: 9783540267843
Edition: 1
Price: CHF 135.50
Publication date: 01/01/2006
Category: Medizin & Pharmazie
Language: English
Technical Data
Pages: 450
Kopierschutz: DRM
Geräte: PC/MAC/eReader/Tablet
Formate: PDF
Table of contents

This comprehensive clinical handbook for nurses in pediatric hematology/oncology, authored by nurse experts from the United Kingdom and North America, contains in-depth information regarding pathophysiology, diagnosis, treatment, advanced assessment, and interventions. The book is divided into 5 sections: pediatric cancers, hematologic disorders, treatment of childhood cancer, side effects of treatment and disease, and supportive and palliative care. It is organized in a user-friendly format with quick reference guides for the nurse. With the ongoing, challenging developments faced during the clinical nursing care of children with cancer, this handbook will provide an indispensable tool for those working in this speciality.

Written for:
Pediatric oncology nurses, pediatric hematology nurses, pediatric nurses, nursing educators, nursing faculty

advanced practice nursing
pediatric hematology
pediatric nursing
pediatric oncology

Table of contents

Chapter 9
Radiation Therapy
(S. 195-196)

Joan M. O’Brien · Deborah Tomlinson

Radiotherapy has had a role in malignancies for the last century. X-rays were discovered by Von Roentgen in 1895 and were used diagnostically.The element radium was isolated by Marie and Pierre Curie in 1898. The first therapeutic report of a patient cures by radiation therapy was in 1899. However it has a diminishing role in childhood malignancies due to more effective chemotherapy regimens and the recognition of late effects of radiation treatment. Children will often be assessed on an individual level regarding the need of radiotherapy. However it is still required for around 20% of children and young people with cancer. Focus in radiation therapy (XRT) has been on methods of delivery that will minimize injury to normal tissues, to try to avoid long-term negative sequalae.

9.1 Principles of treatment

Radiotherapy causes damage to cells in a localised area. Ionising radiation both causes and treats cancer. Damage is caused by breaking strands of DNA, either double or single strands. This inhibits cell division. It may harm normal cells in the area they pass through or in the area around tumor. Radiation treatment has three main roles in the treatment of childhood and young person:

- Radical: Treatment with curative intent
- Adjuvant: "Added on" treatment
- Palliative: Treatment aimed at symptom control

Radiation is frequently used as part of a bone marrow ablative regimen. At times radiation may be used to ameliorate side effects from tumors that are threaten life or organ function, to quickly reduce the size of a mass that is impinging on the airway, or to relieve pressure on the spinal cord to decrease or prevent paralysis. Palliative radiotherapy is given to relieve pain in progressive or metastatic disease. It provides shrinkage of tumor to relieve pain and/or obstructions interfering with quality of life. The dose is monitored to ensure minimal toxicities.

9.2 Description of treatment

All radiation emits radiant energy, either in waves and particle form.

- Electrons are electromagnetic and produced from a linear accelerator. They can provide treatment to super.cial tumors and have increased absorption to bone.(X-rays are electromagnetic radiation that is produced extranuclearly, electrons are accelerated to high energy and then stopped abruptly at a tungsten target (Farah and Weichselbaum 1994)).
- Gamma rays are electromagnetic radiation produced intranuclearly from a radioactive source. They provide local and wide-.eld radiation, and are skin sparing. Gamma rays require lead or concrete to absorb them.
- Protons are high energy atoms, emitted from a machine, for the treatment of tumours needing speci.c dose localization. They are delivered by stereotaxis (a form of radiation that delivers the beam in an extremely precise manner).

9.2.1 Cell radiosensitivity

Factors that contribute to cell radiosensitivity include:
- Phase of cell cycle that cell is in: Studies have shown that cells are most radiosensitive in the M and G2 phases and most resistant in late S phase (Farah and Weichselbaum 1994). Between dose fractions, cells may move through the cell cycle to more sensitive phases. This process is called “reassortment”. This allows for a greater cell kill.

Table of contents <
Chapter 1 Leukemia24
1.1 Acute Lymphoblastic Leukemia25
1.2 Acute Myeloid Leukemia39
1.3 Chronic Myeloid Leukemia43
1.4 Juvenile Myelomonocytic Leukemia44
1.5 Langerhans Cell Histiocytosis45
Chapter 2 Solid Tumors48
2.1 Hodgkins Disease49
2.2 Non-Hodgkins Lymphoma53
2.3 Ewings Sarcoma Family of Tumors60
2.4 Osteosarcoma64
2.5 Liver Tumors68
2.6 Neuroblastoma73
2.7 Renal Tumors80
2.8 Retinoblastoma85
2.9 Rhabdomyosarcoma89
2.10 Non-rhabdomyosarcomatous Soft Tissue Sarcomas94
2.11 Germ Cell Tumors96
2.12 Rare Tumors100
Chapter 3 Common Central Nervous System Tumors108
3.1 Causes/Epidemiology109
3.2 Distribution/Classification109
3.3 Staging110
3.4 Molecular Genetics of Brain Tumors110
3.5 Diagnosis110
3.6 Specialist Referral112
3.7 Hydrocephalus112
3.8 Treatment112
3.9 Prognosis114
3.10 Specific Tumors115
3.11 Follow-up123
3.12 The Late Effects and Rehabilitation of Survivors123
3.13 Palliative Care123
3.14 Future Perspectives/New Innovations123
Chapter 4 Anemias126
4.1 Anemia127
4.2 Iron Deficiency Anemia129
4.3 Sickle Cell Disease132
4.4 Thalassemia141
4.5 Hemolytic Anemia144
4.6 Bone Marrow Failure Syndromes149
Chapter 5 Neutropenia157
5.1 Epidemiology157
5.2 Etiology158
5.3 Symptoms and Clinical Signs159
5.4 Diagnostic Testing159
5.5 Treatment159
5.6 Prognosis161
5.7 Follow-up161
Chapter 6 Thrombocytopenia163
6.1 Epidemiology163
6.2 Etiology164